Find and download the latest information about EXCEDE®:
EXCEDE is part of the BRD Solutions portfolio. Visit BRD-Solutions.com to learn more about the full portfolio of solutions and find expert advice and tools to help customize a BRD program to your needs.
Tissue distribution of ceftiofur and related metabolites after administration of EXCEDE
Feed intake response following a single dose of EXCEDE or Nuflor®
EXCEDE vs. Micotil® for control of bovine respiratory disease using a post-metaphylaxis interval
Duration of therapy with EXCEDE or Micotil in a bovine respiratory disease challenge model
Outcomes of 3-, 5- or 7-day post-treatment intervals after a single administration of EXCEDE
Efficacy of EXCEDE followed by 3- or 7-day post-treatment intervals vs. Baytril® followed by a 3-day post-treatment interval in treatment of bovine respiratory disease
Subcutaneous ear route of administration — a new and patented method for delivering liquid anti-infectivesOpens in a new window
IMPORTANT SAFETY INFORMATION FOR CATTLE: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. See full Prescribing InformationOpens in a new window.
Baytril is a registered trademark of Bayer Aktiengesellschaft. Micotil is a registered trademark of Eli Lilly and Company, its subsidiaries or affiliates. Nuflor is a registered trademark of Intervet Inc. or an affiliate.